Figure 1.
Treatment trends in RT techniques and doses for evaluable patients with early-stage NKTCL. Proportion of patients receiving IMRT vs 3D-CRT (A) and RT doses ≥ 50 Gy vs <50 Gy (B) between 2000 and 2015.
Treatment trends in RT techniques and doses for evaluable patients with early-stage NKTCL. Proportion of patients receiving IMRT vs 3D-CRT (A) and RT doses ≥ 50 Gy vs <50 Gy (B) between 2000 and 2015.